ReviewTherapeutic innovation & regulatory science2026

Regulatory Challenges and Opportunities: A Review of U.S. Food and Drug Administration-Approved Artificial Intelligence and Machine Learning-Enabled Cardiovascular Devices.

Mahima Saini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.